ATM and neoplasm: CHK1/2, serving as key downstream effector molecules of the ATR and ATM signaling pathways, primarily trigger cell cycle arrest by precisely regulating G1/S and G2/M checkpoints, thereby exerting core regulatory functions in the DDR network of tumor cells [75].